RVTY vs. A, MTD, WAT, ILMN, AVTR, BRKR, BIO, BIO.B, OLK, and TXG
Should you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Avantor (AVTR), Bruker (BRKR), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Olink Holding AB (publ) (OLK), and 10x Genomics (TXG). These companies are all part of the "analytical instruments" industry.
Revvity (NYSE:RVTY) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, community ranking, risk and valuation.
86.7% of Revvity shares are owned by institutional investors. 0.6% of Revvity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Revvity has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500.
Agilent Technologies has higher revenue and earnings than Revvity. Agilent Technologies is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.
Agilent Technologies received 842 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 71.70% of users gave Agilent Technologies an outperform vote while only 54.55% of users gave Revvity an outperform vote.
Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Agilent Technologies pays an annual dividend of $0.94 per share and has a dividend yield of 0.7%. Revvity pays out 23.1% of its earnings in the form of a dividend. Agilent Technologies pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio.
Revvity currently has a consensus price target of $118.17, indicating a potential upside of 8.15%. Agilent Technologies has a consensus price target of $137.19, indicating a potential upside of 5.20%. Given Revvity's higher possible upside, equities analysts clearly believe Revvity is more favorable than Agilent Technologies.
Agilent Technologies has a net margin of 18.84% compared to Revvity's net margin of 5.49%. Agilent Technologies' return on equity of 26.25% beat Revvity's return on equity.
In the previous week, Agilent Technologies had 35 more articles in the media than Revvity. MarketBeat recorded 43 mentions for Agilent Technologies and 8 mentions for Revvity. Revvity's average media sentiment score of 1.29 beat Agilent Technologies' score of 0.22 indicating that Revvity is being referred to more favorably in the media.
Summary
Agilent Technologies beats Revvity on 15 of the 20 factors compared between the two stocks.
Get Revvity News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RVTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
